US stock futures dip as Trump’s firing of Cook sparks Fed independence fears
Investing.com - OptiNose reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
OptiNose announced earnings per share of $-0.180 on revenue of $20.1M. Analysts polled by Investing.com EPS of $-0.190 on revenue of $23.55M.
OptiNose 's are down 24% and is trading at $3.000 , still down 24.42% from its 52 week high of $4.30 set on Wednesday, August 17, 2022.
OptiNose shares lost 7.69% to trade at $3.000 in pre-market trade the report.
OptiNose follows other major Healthcare sector earnings this month
OptiNose's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar